Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
General Topic: Clinical Science

11S101: Review Course

Saturday, November 11, 2023
7:30 AM – 2:30 PM PT
Location: Exhibit Hall A-B
CE: 5.5

On Demand In Person Livestreamed

    Moderator(s)

  • Noelle A. Rolle, MBBS

    Medical College of Georgia at Augusta University
    Evans, GA, United States

    Disclosure information not submitted.

  • Julie Schwartzman-Morris, MD, MS

    Rheumatologist
    Northwell Health Physician Partners
    roslyn heights, NY, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

    • Speaker(s)

  • Francesco Boin, MD

    Cedars-Sinai Medical Center
    Los Angeles, CA, United States

    Disclosure(s): Boehringer-Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, November 25, 2021); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Leonard Calabrese, DO

    Board Certified Rheumatologist and the Head, Section of Clinical Immunology Department of Rheumatic & Immunologic Disease
    Cleveland Clinic
    Cleveland, OH, United States

    Disclosure(s): Amgen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Genentech: Consultant (Terminated); GlaxoSmithKlein(GSK): Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • MC

    Megan Clowse, MD, MPH

    Duke University
    Chapel Hill, NC, United States

    Disclosure(s): GlaxoSmithKlein(GSK): Consultant (Ongoing), Grant/Research Support (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing)

  • MF

    Marcela Ferrada, MD

    National Institutes of Health
    Bethesda, MD, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • Laura Kopplin, MD, PhD

    University of Wisconsin-Madison
    Madison, WI, United States

    Disclosure(s): ACELYRIN: Grant/Research Support (Ongoing); Roche: Grant/Research Support (Ongoing)

  • Alexis Ogdie, MD

    Rheumatologist, Associate Professor of Medicine
    University of Pennsylvania
    Philadelphia, PA, United States

    Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Celgene: Consultant (Ongoing); CorEvitas: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead: Consultant (Ongoing); GSK: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Takeda: Consultant (Ongoing); UCB: Consultant (Ongoing)

  • TO

    Thomas Ortel, MD, PhD

    Duke University
    Durham, NC, United States

    Disclosure(s): Sanofi: Consultant (Terminated); Siemens: Grant/Research Support (Ongoing); Stago: Grant/Research Support (Ongoing); Werfen: Consultant (Ongoing), Grant/Research Support (Ongoing)

  • RS

    Rebecca Sadun, MD, PhD

    Duke University
    Durham, NC, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

The ACR Review Course consists of eight lectures spanning the scope of rheumatology. This full-day session is designed to provide a comprehensive update for practitioners.

Learning Objectives:

  • Summarize up-to-date assessment and management strategies in osteoarthritis.
  • Identify current imaging modalities used to diagnose osteoarthritis.
  • Recognize future directions for drug development in osteoarthritis.

Presentations:

  • 7:30 AM – 8:00 AM PT
    Inflammatory Eye Disease: Diagnosis and Treatment Strategies

    Speaker: Laura Kopplin, MD, PhD – University of Wisconsin-Madison

  • 8:00 AM – 8:10 AM PT
    Q&A
  • 8:10 AM – 8:40 AM PT
    Transition of Care Concerns in JIA  

    Speaker: Rebecca Sadun, MD, PhD – Duke University

  • 8:40 AM – 8:50 AM PT
    Q&A
  • 8:50 AM – 9:20 AM PT
    Thrombotic Microangiopathy: Challenging Cases and Treatments

    Speaker: Thomas Ortel, MD, PhD – Duke University

  • 9:20 AM – 9:30 AM PT
    Q&A
  • 9:30 AM – 10:00 AM PT
    An Update on Relapsing Polychondritis

    Speaker: Marcela Ferrada, MD – National Institutes of Health

  • 10:00 AM – 10:10 AM PT
    Q&A
  • 10:10 AM – 10:40 AM PT
    Break
  • 10:40 AM – 11:10 AM PT
    SpA Update: Radiographic and Non-Radiographic AS

    Speaker: Alexis Ogdie, MD – University of Pennsylvania

  • 11:10 AM – 11:20 AM PT
    Q&A
  • 11:20 AM – 11:50 AM PT
    Systemic Sclerosis Screening for Organ Involvement

    Speaker: Francesco Boin, MD – Cedars-Sinai Medical Center

  • 11:50 AM – 12:00 PM PT
    Q&A
  • 12:00 PM – 1:00 PM PT
    Break
  • 1:00 PM – 1:30 PM PT
    Reproductive Counseling

    Speaker: Megan Clowse, MD, MPH – Duke University

  • 1:30 PM – 1:40 PM PT
    Q&A
  • 1:40 PM – 2:10 PM PT
    Clinical Challenges of Viral Infections and Rheumatic Diseases

    Speaker: Leonard H. Calabrese, DO – Cleveland Clinic

  • 2:10 PM – 2:20 PM PT
    Q&A
  • 2:20 PM – 2:30 PM PT
    Wrap Up

    Moderator: Noelle A. Rolle, MBBS – Medical College of Georgia at Augusta University

    Moderator: Julie Schwartzman-Morris, MD, MS – Northwell Health Physician Partners